SG11201406160QA - Method for producing reagent for antibody detection and use thereof - Google Patents

Method for producing reagent for antibody detection and use thereof

Info

Publication number
SG11201406160QA
SG11201406160QA SG11201406160QA SG11201406160QA SG11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA SG 11201406160Q A SG11201406160Q A SG 11201406160QA
Authority
SG
Singapore
Prior art keywords
antibody detection
producing reagent
reagent
producing
antibody
Prior art date
Application number
SG11201406160QA
Other languages
English (en)
Inventor
Junichiro Futami
Kazuhiro Kakimi
Ryuji Maekawa
Masato Shiraki
Original Assignee
Junichiro Futami
Medinet Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Junichiro Futami, Medinet Co Ltd filed Critical Junichiro Futami
Publication of SG11201406160QA publication Critical patent/SG11201406160QA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
SG11201406160QA 2012-03-30 2013-03-29 Method for producing reagent for antibody detection and use thereof SG11201406160QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012082735 2012-03-30
PCT/JP2013/059692 WO2013147233A1 (ja) 2012-03-30 2013-03-29 抗体検出用試薬の製造方法、及びその用途

Publications (1)

Publication Number Publication Date
SG11201406160QA true SG11201406160QA (en) 2014-11-27

Family

ID=49260472

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201406160QA SG11201406160QA (en) 2012-03-30 2013-03-29 Method for producing reagent for antibody detection and use thereof

Country Status (8)

Country Link
US (2) US10822384B2 (ja)
EP (1) EP2833143B1 (ja)
JP (1) JP6168497B2 (ja)
CN (1) CN104380106B (ja)
AU (1) AU2013240942B2 (ja)
SG (1) SG11201406160QA (ja)
TW (1) TWI582424B (ja)
WO (1) WO2013147233A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104380106B (zh) * 2012-03-30 2017-02-22 二见淳一郎 用于生产抗体检测试剂的方法及其用途
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
DK3388075T5 (da) 2015-03-27 2024-09-23 Immatics Biotechnologies Gmbh Hidtil ukendte peptider og kombination af peptider til anvendelse ved immunterapi mod forskellige tumorer
US11709165B2 (en) 2017-05-11 2023-07-25 Kawasaki Gakuen Educational Foundation Examination method for prediction of effect of treatment of cancer based on detection of cancer/testis antibodies
GB201803750D0 (en) * 2018-03-08 2018-04-25 Immunocore Ltd Method
CN111647066B (zh) * 2020-07-01 2020-12-18 维肽瀛(上海)生物技术有限公司 Wt1多肽肿瘤抑制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3225468B2 (ja) 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
US6589736B1 (en) * 1994-11-22 2003-07-08 The Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
WO2002010760A1 (fr) * 2000-07-27 2002-02-07 Kyowa Medex Co., Ltd Technique relative a une epreuve d'immunite menee avec des particules d'un vehicule insoluble et reactif a cet effet
JP4833831B2 (ja) * 2003-03-31 2011-12-07 ウイミンズ、アンド、チルドランズ、ホスピトル リソソーム蓄積症（ｌｄｓ）の多重スクリーニング
JP3960614B2 (ja) 2003-08-31 2007-08-15 株式会社イムノディア 抗ペプチド抗体測定法とペプチドワクチンのワクチン候補選択方法
JP2005098877A (ja) 2003-09-25 2005-04-14 Hitachi Software Eng Co Ltd 抗体検出体、その製造方法、及び抗体検出方法
US7838305B2 (en) 2004-03-08 2010-11-23 The United States Of America As Represented By The Department Of Health And Human Services Autoantibody detection for cancer diagnostics
EP1650297B1 (en) * 2004-10-19 2011-04-13 Samsung Electronics Co., Ltd. Method and apparatus for the rapid disruption of cells or viruses using micro magnetic beads and laser
CN100406889C (zh) * 2005-07-15 2008-07-30 北京倍爱康生物技术股份有限公司 一种人甲状腺球蛋白抗体磁分离酶促化学发光免疫检测方法
JP4660431B2 (ja) 2006-06-22 2011-03-30 株式会社アルバック 生体物質検出・回収方法およびその装置及び生体物質解析方法
FR2908414B1 (fr) * 2006-11-13 2012-01-20 Centre Nat Rech Scient Immobilisation de proteines membranaires sur un support par l'intermediaire d'une molecule amphiphile
JP2008233007A (ja) * 2007-03-23 2008-10-02 Osaka Industrial Promotion Organization 悪性リンパ腫の診断用キット及び判定方法
CN101452001B (zh) * 2007-12-06 2013-07-24 王颖 化学发光磁酶免疫法定量检测rbp4试剂盒
JP5326454B2 (ja) 2008-09-18 2013-10-30 大同特殊鋼株式会社 バッチ式熱処理炉
CN101403747B (zh) * 2008-11-07 2012-08-29 浙江伊利康生物技术有限公司 补体3检测试剂
CN101551394A (zh) * 2009-05-13 2009-10-07 郑州安图绿科生物工程有限公司 以磁性微粒为载体检测丙型肝炎病毒抗体的方法
CA2794217C (en) * 2010-03-25 2018-01-02 National University Corporation Okayama University Thiosulfonate compound, reversible cationization agent for protein and/or peptide, and method for solubilization
CN104380106B (zh) * 2012-03-30 2017-02-22 二见淳一郎 用于生产抗体检测试剂的方法及其用途

Also Published As

Publication number Publication date
EP2833143A1 (en) 2015-02-04
US20210032302A1 (en) 2021-02-04
JPWO2013147233A1 (ja) 2015-12-14
TW201400814A (zh) 2014-01-01
TWI582424B (zh) 2017-05-11
EP2833143A4 (en) 2015-11-11
JP6168497B2 (ja) 2017-07-26
EP2833143B1 (en) 2019-04-24
CN104380106A (zh) 2015-02-25
US20150064801A1 (en) 2015-03-05
AU2013240942B2 (en) 2018-07-05
US10822384B2 (en) 2020-11-03
WO2013147233A1 (ja) 2013-10-03
AU2013240942A1 (en) 2014-11-13
CN104380106B (zh) 2017-02-22

Similar Documents

Publication Publication Date Title
IL257714B (en) Systems and methods for the analysis of multiple analytes
HK1207422A1 (en) Device and method for detection of analytes
EP2917734A4 (en) SYSTEM AND METHOD FOR DETECTION OF CANCER BASED ON SERUM
EP2884270A4 (en) METHOD FOR DETECTING BIOMOLECULES, DEVICE FOR DETECTING BIOMOLECULES, AND DEVICE FOR ANALYZING
EP2812676A4 (en) METHODS AND SYSTEMS FOR SAMPLE ANALYSIS
EP2888274A4 (en) DEVICE AND METHOD FOR REALIZING BLOOD ASSAYS BY MAGNETIC DETECTION THROMBOELATOGRAPHY
HRP20190030T1 (hr) Postupak pročišćavanja protutijela
HK1168649A1 (en) Method and device for assay determination
EP2861623A4 (en) NEW SPECIFIC CLEC14A ANTIBODY AND USES THEREOF
EP2900265A4 (en) ANTI-UROPLAKIN II ANTIBODY SYSTEMS AND ASSOCIATED METHODS
EP2909346A4 (en) PROCESS AND SYSTEM FOR SAMPLE PREPARATION
PL2901131T3 (pl) Układ i sposób do wytwarzania próbek analitycznych
EP2899538A4 (en) BIOSENSOR AND MANUFACTURING PROCEDURE FOR THE BIOSENSOR
PL2633914T3 (pl) Urządzenie do pipetowania i sposób jego wytwarzania
EP2902782A4 (en) IMMUNOLOGICAL DETECTION METHOD AND REAGENT FOR IMMUNOLOGICAL DETECTION
SG11201406160QA (en) Method for producing reagent for antibody detection and use thereof
HK1203354A1 (en) Anti-theophylline antibodies and methods of use
EP2833141A4 (en) IMMUNOLOGICAL ANALYSIS METHOD AND REAGENT
PL2823309T3 (pl) Sposób i urządzenie do wykrywania analitów
IL234932B (en) Method and structure for chemical analysis
HK1196982A1 (zh) 標定試劑和方法
EP2841943C0 (en) METHOD FOR THE CHARACTERIZATION AND/OR DETERMINATION OF SAMPLES
PL2981824T3 (pl) Sposób do wykrywania przeciwciał swoistych wobec aSyn w próbce biologicznej
EP2919010A4 (en) METHOD FOR TESTING NEPHRITE LESION SITES AND RELATED REACTIVE
GB201217783D0 (en) Analyte detection device and method